PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
Datasea's AI Agent Digital Marketing Services Enter Scaled Commercial Deployment, with Five Agreements Representing Potential Annualized Service Volume of Up to Approximately US$89.4 Million (RMB600 Million)
2026-09-17T    Computer Software   Computer/Electronics   Internet Technology   Medical/Pharmaceuticals 
New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline
2026-09-17T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
ZEISS expands retinal imaging portfolio with new ZEISS ALTA DUO 300
2026-09-17T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
There's No One-Size-Fits-All for Treating Older Adults with Cancer, According to New NCCN Patient Resource
2026-09-17T    Health Care/Hospital   Medical/Pharmaceuticals 
Dr. Alison Armour agrees to become Chief Medical Officer of Alpha Fusion, as Company Advances Integration of At-211 Businesses with Curadh MTR
2026-09-17T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
2026-09-17T    Health Care/Hospital   Medical/Pharmaceuticals   Retail 
WuXi XDC Out-Licenses WuXiTecan-2 Payload-Linker Technology Platform to Ona Therapeutics to Advance Novel ADC Research and Development
2026-09-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
2026-09-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
111, Inc. Announces Second Quarter 2026 Unaudited Financial Results
2026-09-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals   Multimedia/Online/Internet 
Akeso's EGFR/TROP2 Bispecific ADC AK158D1 Granted NMPA Phase I Clearance for Advanced Solid Tumors, Marking Its Fourth Clinical-Stage ADC Candidate
2026-09-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.